- Exchange: Berlin
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Medizone International Inc+ Add to Watchlist
NCK:GR0.074 EUR 0.005 7.25%
As of 13:37:16 ET on 05/05/2015.
Company Profile for Medizone International Inc (NCK)
Medizone International, Inc. researches and develops ozone based treatment for diseases and health problems caused by lipid enveloped viruses such as Hepa- titus B. The Company is also developing technology for the decontamination of blood, blood products, and veterinarian serum products.
Medizone International Inc
Key Executives for Medizone International Inc (NCK)
|Edwin G MarshallChairman/CEO||Michael E ShannonPresident/Dir:Medical Affairs|
|Thomas E Auger "Tommy"Chief Financial Officer|